Showing results (61-70 of 497) with videos related to

Sort By:
Pageof 50
Journal of Clinical Microbiology|December 1, 1995
Simple enzyme immunoassay for titration of antibodies to the CD4-binding site of human immunodeficiency virus type 1 gp120I Turbica, M Posner, C Bruck, et al.
Biometrics|June 1, 1993
Random-effects models, for longitudinal data using Gibbs samplingW R Gilks, C C Wang, B Yvonnet, et al.
Research in Virology|January 1, 1994
Hepatitis type E in a French population: detection of anti-HEV by a synthetic peptide-based enzyme-linked immunosorbent assayP Coursaget, N Depril, Y Buisson, et al.
Journal of Medical Virology|February 1, 1993
Hepatitis E and hepatitis C virus infections among French soldiers with non-A, non-B hepatitisP Coursaget, K Krawczynski, Y Buisson, et al.
Scandinavian Journal of Gastroenterology|April 1, 1997
Detection of antibodies to hepatitis E virus in patients with autoimmune chronic active hepatitis and primary biliary cirrhosisP Le Cann, M J Tong, J Werneke, et al.
FEMS Microbiology Letters|March 12, 1998
Production of recombinant virus-like particles from human papillomavirus types 6 and 11, and study of serological reactivities between HPV 6, 11, 16 and 45 by ELISA: implications for papillomavirus prevention and detectionA Touzé, C Dupuy, D Mahé, et al.
AIDS (London, England)|October 28, 1997
Increasing diversity of HIV-1M serotypes in French blood donors over a 10-year period (1985-1995). Retrovirus Study Group of the French Society of Blood TransfusionF Barin, A M Courouce, J Pillonel, et al.
Journal of Virology|October 9, 1999
Nasal immunization of mice with human papillomavirus type 16 (HPV-16) virus-like particles or with the HPV-16 L1 gene elicits specific cytotoxic T lymphocytes in vaginal draining lymph nodesC Dupuy, D Buzoni-Gatel, A Touzé, et al.
FEMS Microbiology Letters|July 15, 1996
Production of human papillomavirus type 45 virus-like particles in insect cells using a recombinant baculovirusA Touzé, C Dupuy, M Chabaud, et al.
Vaccine|January 1, 1995
Simultaneous injection of plasma-derived or recombinant hepatitis B vaccines with yellow fever and killed polio vaccinesP Coursaget, B Fritzell, C Blondeau, et al.
Pageof 50